Press Releases :: IceCure Medical Ltd. (ICCM)

Skip to main content Skip to section navigation Skip to footer

Nov 29, 2021 1:07 pm EST

IceCure Medical Announces Appointment of Merav Nir Dotan to Vice President Human Resources

Nov 23, 2021 8:00 am EST

IceCure Medical Reports Financial Results as of and for the first Nine Months of 2021 and Recent Corporate Developments

Nov 01, 2021 9:05 am EDT

IceCure Medical Announces New Independent Data Published in the Journal of Cancer Therapy Showing that Percutaneous Cryoablation Presents a Potential Substitute for Lumpectomy for Tumors <15mm using ProSense™

Oct 20, 2021 8:15 am EDT

IceCure Medical Enters into an Exclusive Agreement in Poland for Distribution of the ProSense™ Cryoablation System

Oct 12, 2021 8:00 am EDT

IceCure Medical Announces Updated Regulatory Strategy in China for the IceSense3® System to Treat Cancerous Tumors with Cryoablation

Sep 23, 2021 5:00 pm EDT

IceCure Medical Reports Financial Results for the First Half of 2021 and Recent Operating Highlights

Sep 13, 2021 7:00 am EDT

IceCure Medical Announces First Peer Reviewed Publication for the 3-Year Interim Analysis of the ICE3 Trial on Cryoablation of Low-Risk, Early-Stage Breast Cancer

Sep 01, 2021 8:00 am EDT

IceCure Medical Announces Exclusive Distribution Agreement to Sell ProSense™ Cryoablation System in Turkey

Aug 26, 2021 7:00 am EDT

IceCure Medical Shares to Begin Trading on Nasdaq Capital Market on August 26, 2021

Aug 09, 2021 8:00 am EDT

/C O R R E C T I O N -- IceCure Medical/

Select a page:

rss_feed News RSS

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

© 2025 All Rights Reserved IceCure Medical

Branding by

Terms of Use | Privacy | Last Updated: April 9, 2023